Skip to main content

Table 1 Characteristics of surgical cancer patients

From: Effect of the molecular targeted drug, erlotinib, against endometrial cancer expressing high levels of epidermal growth factor receptor

  Well differentiated Mediate differentiated Poorly differentiated P value
(G1) (n = 4) (G2) (n = 17) (G3) (n = 10)  
Age 57 (50–63) 59 (56–66) 58 (52–61) ns
BMI 22.2 (20.0–28.6) 23.4 (20.3–25.0) 21.4 (20.7–23.6) ns
FIGO Surgical Stage     ns
 I 16 (66.7 %) 10 (58.8 %) 5 (50.0 %)  
 II 3 (12.5 %) 1 (5.9 %) 0 (0.0 %)  
 III 4 (16.7 %) 6 (35.3 %) 3 (30.0 %)  
 IV 1 (4.2 %) 0 (0 %) 2 (20.0 %)  
  1. Median (Interquartile Range). FIGO International Federation of Gynecology and Obstetrics